瓣膜性心脏病介入治疗

The interventional treatment of valvular heart disease

瓣膜性心脏病是一种常见的心脏疾病,退行性瓣膜病的发病率逐年升高,尤其是退行性主动脉瓣狭窄。退行性瓣膜病患者多为高龄且合并多种疾病,而人工生物瓣膜的衰败使患者面临二次手术的风险,故其治疗上,传统的外科手术风险极高,介入技术的发展为这类患者的治疗带来了新的希望,文章对近年来在临床上广泛使用的各类瓣膜病介入治疗技术做一概述。

Valvular heart disease is a common heart disease, and the incidence of degenerative valvular disease rate in- creased year by year, especially the degenerative aortic valve stenosis. Developments in the field of invasive cardiology have led to percutaneous valve repair and replacement becoming a reality. Patients selected for these procedures are deemed too high risk for conventional surgery. They are often elderly, have severe primary valvular disease and multiple co-morbidities. This article summarises these procedures, reviews the published device issues relevant to percutaneous valve repair.